Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Porcellati

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Hypertension (Dallas, Tex. : 1979)|August 1, 1996
Association between persistent pressure overload and ventricular arrhythmias in essential hypertensionG Schillaci, P Verdecchia, C Borgioni, et al.
Clinical Pharmacology and Therapeutics|September 1, 1996
Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: a comparative study of the efficacy and safety against amlodipineL Corea, O Cardoni, R Fogari, et al.
The American Journal of Cardiology|October 1, 1994
Improved electrocardiographic diagnosis of left ventricular hypertrophyG Schillaci, P Verdecchia, C Borgioni, et al.
Circulation|October 27, 1999
Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertensionP Verdecchia, G Reboldi, G Schillaci, et al.
The American Journal of Cardiology|July 15, 1996
Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophyP Verdecchia, G Schillaci, C Borgioni, et al.
Journal of the American College of Cardiology|March 15, 1995
Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular massP Verdecchia, G Schillaci, C Borgioni, et al.
The American Journal of Cardiology|October 29, 1992
Evaluation of the antihypertensive effect of once-a-day trandolapril by 24-hour ambulatory blood pressure monitoring. The Italian Trandolapril Study GroupG Mancia, R De Cesaris, R Fogari, et al.
Journal of Cardiovascular Pharmacology|January 1, 1994
Twenty-four-hour ambulatory blood pressure monitoring and antihypertensive treatment: focus on ACE inhibitorsA Ravogli, S Omboni, R De Cesaris, et al.
Minerva Medica|January 1, 1992
[Evaluation of the safety and efficacy of the lisinopril + hydrochlorothiazide and captopril + hydrochlorothiazide combinations in the treatment of essential arterial hypertension]A Rappelli, G B Ambrosio, A Caiazza, et al.
Minerva Medica|January 1, 1989
[Multicenter clinical study of the antihypertensive activity of lisinopril]G A Cinotti, A Bossini, V Cagli, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Hypertension (Dallas, Tex. : 1979)|August 1, 1996
Association between persistent pressure overload and ventricular arrhythmias in essential hypertensionG Schillaci, P Verdecchia, C Borgioni, et al.
Clinical Pharmacology and Therapeutics|September 1, 1996
Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: a comparative study of the efficacy and safety against amlodipineL Corea, O Cardoni, R Fogari, et al.
The American Journal of Cardiology|October 1, 1994
Improved electrocardiographic diagnosis of left ventricular hypertrophyG Schillaci, P Verdecchia, C Borgioni, et al.
Circulation|October 27, 1999
Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertensionP Verdecchia, G Reboldi, G Schillaci, et al.
The American Journal of Cardiology|July 15, 1996
Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophyP Verdecchia, G Schillaci, C Borgioni, et al.
Journal of the American College of Cardiology|March 15, 1995
Adverse prognostic significance of concentric remodeling of the left ventricle in hypertensive patients with normal left ventricular massP Verdecchia, G Schillaci, C Borgioni, et al.
The American Journal of Cardiology|October 29, 1992
Evaluation of the antihypertensive effect of once-a-day trandolapril by 24-hour ambulatory blood pressure monitoring. The Italian Trandolapril Study GroupG Mancia, R De Cesaris, R Fogari, et al.
Journal of Cardiovascular Pharmacology|January 1, 1994
Twenty-four-hour ambulatory blood pressure monitoring and antihypertensive treatment: focus on ACE inhibitorsA Ravogli, S Omboni, R De Cesaris, et al.
Minerva Medica|January 1, 1992
[Evaluation of the safety and efficacy of the lisinopril + hydrochlorothiazide and captopril + hydrochlorothiazide combinations in the treatment of essential arterial hypertension]A Rappelli, G B Ambrosio, A Caiazza, et al.
Minerva Medica|January 1, 1989
[Multicenter clinical study of the antihypertensive activity of lisinopril]G A Cinotti, A Bossini, V Cagli, et al.
Pageof 9